ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 302

Accuracy of Systemic Lupus International Collaborating Clinics Classiffication Criteria Applied to Juvenile Systemic Lupus Erythematosus Patients

Marìa M. Katsicas1, Ezequiel Borgia2, Ileana Villarroel2 and Ricardo Russo3, 1Service of Immunology & Rheumatology. Hospital de Pediatrìa Prof Dr.Juan.P. Garrahan, MD, Buenos Aires, Argentina, 2Service of Immunology & Rheumatology. Hospital de Pediatrìa Prof Dr.Juan.P. Garrahan, MD, Caba, Argentina, 3Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: classification criteria, pediatrics and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) is a prototype autoimmune disease. The most widely used classification criteria for SLE were those developed by the American College of Rheumatology (ACR) in 1982 and revised by a committee in 1997, but not validated in that revision. The Systemic Lupus Collaborating Clinics (SLICC) revised the ACR SLE classification criteria and validated new criteria in order to improve clinical relevance and incorporate new knowledge in SLE immunology .

 To assess sensitivity and specificity of revised and validated new SLICC SLE classification criteria in a cohort of Juvenile SLE patients.

Methods: The SLICC criteria rule for SLE classification requires: 1) four criteria, with at least one clinical criterion and one immunologic criterion or 2) lupus nephritis alone in the presence of ANA or anti-DNA antibodies. Seventeen criteria were identified. Cases were JSLE patients who were attending a single tertiary center in the past 10 years. JSLE had been diagnosed on clinical and immunological grounds by experienced pediatric rheumatologist. Controls were patients with rheumatic diseases other than SLE: Juvenile Idiopathic Arthritis (JIA); Juvenile Dermatomyositis (JDM), Autoimmune Hepatitis (AH) and Juvenile Systemic Sclerosis (JSS). Criteria were reviewed from prospectively developed databases and medical records by pediatric rheumatologists in order to establish the number and frequency of new criteria fulfilled by each patient. Descriptive statistics were used to characterize both patients groups. Summary statistics included overall sensitivity and specificity. McNemar`s test was used to assess differences between ACR 1997 criteria and SLICC criteria with respect to accuracy.

Results: Cases: 107 patients with JSLE were included (F: 89 M: 18 ), age at onset: 12 (3-16) yo. Controls: 102 patients with JIA  (36 patients, systemic 20, polyarticular 16); JDM (28), AH (28) and JSS (10), F:76  M: 26 , age at onset: 11 (2-16) yo. SLICC SLE criteria sensitivity was 100 % vs 86% ACR 1997 criteria, while specificity was 98% vs 96% (p=0.009). Six patients with a clinical diagnosis of JSLE were correctly classified by SLICC but not by ACR criteria.

Table lists the sensitivity and specificity of each criterion in SLICC SLE criteria

 

SLICC SLE criteria

Sensitivity %

Specificity %

 

 

 

Acute cutaneous lupus

61

100

Chronic cutaneous lupus

2

100

Oral ulcers

11

100

Nonscarring alopecia

14

98

Synovitis

65

68

Serositis

13

98

Renal

56

99

Neurologic

11

100

Hemolytic anemia

21

98

Leukopenia or Lymphopenia

34

95

Thrombocytopenia

31

92

ANA

100

60

Anti-DNA

63

100

Anti-Sm

30

100

Antiphospholipid antibodies

33

100

Low complement

91

90

Direct Coombs test

29

98

 

 

 

Conclusion: The SLICC new criteria performed better than the ACR 1997 criteria in a cohort of patients with JSLE. These new criteria allowed better accuracy than previous criteria in some variables such as low complement, anti-DNA,  acute cutaneous lupus, ANA, and renal involvement.


Disclosure:

M. M. Katsicas,
None;

E. Borgia,
None;

I. Villarroel,
None;

R. Russo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accuracy-of-systemic-lupus-international-collaborating-clinics-classiffication-criteria-applied-to-juvenile-systemic-lupus-erythematosus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology